Skip to main content

Products

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

复邦德 - NMPA Drug Approval Details

Approvals/NMPA/Ainuovirine, Lamivudine and Tenofovir Disoproxil Fumarate Tablets

Approved

化学药品

Ainuovirine, Lamivudine and Tenofovir Disoproxil Fumarate Tablets

江苏艾迪药业股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Dec 30, 2022
Approval ID: 1cac45e6a6887bfe
Company: 江苏艾迪药业股份有限公司
Type: 化学药品

Approval Details

Approval Id: 1cac45e6a6887bfe
Approval Number: 国药准字H20220033
Generic Name: 艾诺米替片
Generic Name En: Ainuovirine, Lamivudine and Tenofovir Disoproxil Fumarate Tablets
Trade Name: 复邦德
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含艾诺韦林0.15g,拉米夫定0.3g,富马酸替诺福韦二吡呋酯0.3g
Reg Date: 2022-12-30
Company Name: 江苏艾迪药业股份有限公司
Company Address: 扬州市邗江区新甘泉西路69号
Production Company Name: 江苏艾迪药业股份有限公司
Production Company Address: 扬州市邗江区新甘泉西路69号
Company Detail Path: /organization/a6d77b542749a389/jiangsu-aidea-pharmaceutical-co-ltd
Production Company Detail Path: /organization/a6d77b542749a389/jiangsu-aidea-pharmaceutical-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 30, 2022

Approval ID

1cac45e6a6887bfe

Type

化学药品

Back to NMPA Approvals